جستجوی مقالات مرتبط با کلیدواژه « پیری سلولی » در نشریات گروه « پزشکی »

Nanorobots, also known as nanobots, are promising medical structures with significant potential for revolutionizing medical treatments and preventing their onset. Nanorobotics shows promise for diagnosing, treating, and regenerating age-related diseases. These tiny machines can repair cellular damage, deliver drugs, stimulate tissue regeneration, and monitor treatments. However, their application in controlling cellular aging is in its early stages, requiring more research to fully understand their potential and address safety concerns. Despite this, the benefits of nanorobots in age-related disease management justify further investigation. This narrative review article provides an overview of recent developments in nanorobotics, specifically focusing on its medical applications. PubMed and Google Scholar were utilized to conduct a comprehensive search using relevant keywords including "nanorobots", "cellular aging", "drug delivery systems", "cellular repair", "therapeutics", and "diagnosis". Only articles published between 2005-2023 were selected to support the arguments with up-to-date evidence. The extracted information includes nanorobot design, fabrication methods, applications, and key findings. A quality assessment was performed, and the data were categorized thematically to identify patterns and trends. The article concludes with an examination of the current state and future prospects of nanorobotics in different fields. Our research showed that nanorobots have significant potential in the diagnosis, treatment, and regenerative medicine of age-related diseases. They can detect and repair cellular damage caused by aging, targeting DNA damage and cellular protein misfolding. Nanorobots can also deliver drugs directly to affected areas, reducing side effects. Furthermore, they stimulate tissue regeneration and the growth of new blood vessels by delivering growth factors. Nanorobots can also monitor treatment effectiveness by measuring drug concentration in tumor cells. However, there are concerns about their safety in long-term use that require further research. Overall, nanorobots present an innovative approach to addressing cellular changes in aging, but more research is needed to understand their full potential and address safety concerns. The use of nanorobots in treating cellular aging has opened new possibilities in diagnosing and treating age-related diseases and it is a rapidly evolving field with the potential to revolutionize age-related disease treatment and improve the quality of life globally.

Senescence is linked to increases in oxidative stress and free radicals, which can potentially damage DNA. Furthermore, obesity is known to exacerbate these factors. In contrast, antioxidants may postpone tissue aging, including adipose tissues, by fighting with free radicals. To investigate this link, this study was carried out to assess associations between dietary antioxidant intake and visceral adipose tissue aging in obese adults.

A case-control study was carried out at Shahada Tajrish Hospital, Tehran, Iran, with 20 candidates of bariatric surgery and 20 adults of normal weight. The study assessed activity of beta-galactosidase in visceral adipose tissues. Assessment of dietary antioxidants was carried out using food frequency questionnaires.

Study indicated significant adverse correlations of the daily consumption of vitamin C and selenium with beta-galactosidase activity in visceral fat tissues of case group (p = 0.039 and p = 0.028, respectively). In the control group, significant adverse relationships were observed between the daily intake of vitamin C (p = 0.001), lycopene (p = 0.027), selenium (p = 0.037) and magnesium (p = 0.002) and beta-galactosidase activity in visceral fat tissues. Moreover, individuals with high beta-galactosidase enzyme activity in visceral fat tissues had a significantly lower daily intake of vitamin E (p = 0.046), vitamin C (p < 0.001), lycopene (p = 0.030), selenium (p = 0.035) and magnesium (p = 0.01), compared to those with low beta-galactosidase enzyme activity in visceral fat tissues.

Consuming diets high in antioxidants has been linked to decreased cellular senescence in the visceral adipose tissues of obese adults. To further investigate this relationship, studies including a variety of senescence markers are recommended.

Transplantation of chondrocytes is one of the methods for treatment of articular cartilage defects. For this purpose, it is necessary to isolate these chondrocytes and expand in serum containing culture medium. Sera contain growth factors that are added to medium. Fetal bovine serum (FBS) is used for standard cell culture. However bovine proteins of FBS are accompanied with risk of host immune system reactions. Therefore, it is necessary to replace FBS with human serum for clinical cases. In addition, infants have chondrocytes with high proliferation potency versus adults. In this study, the effects of FBS and human placental serum was investigated on morphology and cellular senescence related genes expression of chondrocytes of infants.

Chondrocytes after isolation of from polydactyly cartilage tissue samples, were cultured in 10% FBS and human serum up to passage 5. Human placental serum was obtained from venous blood of embryonic surface of human placenta. Chondrocytes in two culture medium were compared morphologically by inverted microscope. For cellular senescence evaluation, relative expression of IGF1 and P16 genes were assessed by quantitative real-time RT PCR.

Proliferation of chondrocytes is markedly decreased in FBS groups in comparison with human serum. In FBS containing medium, phenotypes of cells were changed from spindle shape to flat appearance after five passages. The expression IGF1 and P16 genes are increased in chondrocytes grown in FBS containing medium and it was significant about P16. Morphologic results were in agreement with Real-time RT PCR results.

Human placental serum has advantages such as high proliferation rate on human chondrocytes, prevention from cellular senescence and immunological problems in using cultured chondrocytes for cartilage tissue engineering.